JPS56161893U - - Google Patents

Info

Publication number
JPS56161893U
JPS56161893U JP5986480U JP5986480U JPS56161893U JP S56161893 U JPS56161893 U JP S56161893U JP 5986480 U JP5986480 U JP 5986480U JP 5986480 U JP5986480 U JP 5986480U JP S56161893 U JPS56161893 U JP S56161893U
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5986480U
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP5986480U priority Critical patent/JPS56161893U/ja
Publication of JPS56161893U publication Critical patent/JPS56161893U/ja
Pending legal-status Critical Current

Links

JP5986480U 1980-05-02 1980-05-02 Pending JPS56161893U (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5986480U JPS56161893U (de) 1980-05-02 1980-05-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5986480U JPS56161893U (de) 1980-05-02 1980-05-02

Publications (1)

Publication Number Publication Date
JPS56161893U true JPS56161893U (de) 1981-12-02

Family

ID=29654332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5986480U Pending JPS56161893U (de) 1980-05-02 1980-05-02

Country Status (1)

Country Link
JP (1) JPS56161893U (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962700B2 (en) 2006-10-25 2015-02-24 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8980325B2 (en) 2008-05-01 2015-03-17 Revalesio Corporation Compositions and methods for treating digestive disorders
US9011922B2 (en) 2009-04-27 2015-04-21 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9034195B2 (en) 1997-10-24 2015-05-19 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
US9402803B2 (en) 2006-10-25 2016-08-02 Revalesio Corporation Methods of wound care and treatment
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy
US9512398B2 (en) 2006-10-25 2016-12-06 Revalesio Corporation Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034195B2 (en) 1997-10-24 2015-05-19 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US8962700B2 (en) 2006-10-25 2015-02-24 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US9004743B2 (en) 2006-10-25 2015-04-14 Revalesio Corporation Mixing device for creating an output mixture by mixing a first material and a second material
US9402803B2 (en) 2006-10-25 2016-08-02 Revalesio Corporation Methods of wound care and treatment
US9512398B2 (en) 2006-10-25 2016-12-06 Revalesio Corporation Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles
US9511333B2 (en) 2006-10-25 2016-12-06 Revalesio Corporation Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US8980325B2 (en) 2008-05-01 2015-03-17 Revalesio Corporation Compositions and methods for treating digestive disorders
US9011922B2 (en) 2009-04-27 2015-04-21 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9272000B2 (en) 2009-04-27 2016-03-01 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy

Similar Documents

Publication Publication Date Title
FR2476425B1 (de)
FR2474291B1 (de)
FR2474044B1 (de)
FR2474465B1 (de)
FR2474436B1 (de)
FR2476216B1 (de)
JPS57501539A (de)
FR2479066B1 (de)
FR2476537B1 (de)
FR2477888B1 (de)
FR2474835B1 (de)
FR2474153B3 (de)
FR2475148B1 (de)
FR2475928B1 (de)
FR2474589B1 (de)
FR2476604B3 (de)
JPS56161893U (de)
FR2478241B3 (de)
FR2476621B3 (de)
FR2476920B1 (de)
FR2474906B1 (de)
FR2478393B3 (de)
FR2475644B1 (de)
FR2476770B1 (de)
FR2478939B1 (de)